Although direct data are missing for the effects of indole-derivatives in pancreatic adenocarcinoma, the invasive behavior of pancreatic adenocarcinoma cells can be modulated through the selective AHR modulators, Omeprazole and Tranilast [222]. The gene discussed is AHR; the disease is pancreatic adenocarcinoma.